upndown1313

Downturn Has Transformed Drug Company Business Model

Write facts, but wrong interpretation. Big Pharma spending at CRO probably hasn't changed much, but rather the smaller, more virtual biotechs who have dramtically cut back on their spending due to the lack of funds and lack of access to credit markets due to the credit crunch.

Merck’s Gardasil: A Risky and Unnecessary Vaccine

Pamela, don't understand the title of your article, or are you just short Merck and want to jump on the Merck bashing bandwagon. Do you think a parent whose daughter has cervical cancer would say the vaccine is risky and unnecessary? It seems to me, for a vaccine that was tested very safe and 100% effective in a clinical setting , it would be risky not to get the vaccine. Both my daughters received the vaccine, and when it is approved for boys, my son will get it too. I would say, to others, why take the chance with your child's health by not eliminating one type of cancer. In my view, this is both risky and unnecessary.

Is Merck's New Obesity Drug Candidate in Serious Trouble?

Discontinuations due to GI- and psychiatric-related AEs were 0.7%, 1.7%, 2.7% and 4.6%, 8.9%, 12.5%, respectively, for Pbo, 2- and 4- mg groups. Most AEs were mild to moderate in intensity.
Conclusions: Treatment with taranabant for 52 wks led to clinically meaningful weight loss and improvements in metabolic parameters with a favorable risk/benefit profile.